QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 限定条件 内容类型：会议论文    专题：复旦大学上海医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 A PROSPECTIVE, OPEN-LABELED, RANDOMIZED, MULTICENTER PHASE II STUDY TO EVALUATE EFFICACY AND SAFETY OF ERLOTINIB VS NP CHEMOTHERAPY AS ADJUVANT THERAPY IN POST RADICAL OPERATION STAGE IIIA NSCLC PATIENTS WITH EGFR 19 OR 21 EXON MUTATION (EVAN, ML28280, NCT01683175) 会议论文 作者:  Yue, Dongsheng;  Xu, Shidong;  Li, Qiang;  Liu, Junfeng;  Li, Xiaofei 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/19 NSCLC  EGFR mutation  post surgery  erlotinib   A NON-INTERVENTIONAL STUDY ON EGFR MUTATION STATUS AND CLINICAL OUTCOMES OF CHINESE PATIENTS WITH COMPLETELY RESECTED LUNG ADENOCARCINOMA (ICAN STUDY) 会议论文 作者:  Wu, Yi-Long;  Wang, Jun;  Chu, Xiang-Yang;  Liu, Zhi-Dong;  Shen, Yi 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19 adjuvant therapy  DFS  Chinese lung adenocarcinoma  EGFR mutation   A prospective comparison study on EGFR mutations by direct sequencing and ARMS in completely resected Chinese non-small cell lung cancer with adenocarcinoma histology (ICAN) 会议论文 作者:  Zhang, Xuchao;  Wu, Yi Long;  Wang, Jun;  Chu, Xiang-Yang;  Liu, Zhi-Dong 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/19 Update of a phase III trial of adjuvant vinorelbine plus cisplatin (NP) versus NP plus endostar (NPE) in patients with completely resected stage IB-IIIA non-small cell lung cancer (NSCLC) 会议论文 作者:  Jie, He;  Han, Baohui;  Liu, Yongyu;  Wu, Shi Xiu;  Kuang, Yukang 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/19 AN UPDATE OF THE PHASE III STUDY OF ADJUVANT VINORELBINE PLUS CISPLATIN (NP) VERSUS NP PLUS ENDOSTAR (NPE) IN PATIENTS WITH COMPLETELY RESECTED STAGE IB-IIIA NON-SMALL CELL LUNG CANCER (NSCLC) 会议论文 作者:  He, Jie;  Zhang, Xiangru;  Li, Junling;  Han, Baohui;  Liu, Yongyu 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/19 Endostar  Vinorelbine  Cisplatin  Non-small cell lung cancer (NSCLC)